Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Healthwell Acquisition Corp. I - Class A Common Stock (NQ:HWEL)

N/A UNCHANGED

Last Price Updated: 3:47 PM EST, Nov 28, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	10.47 (5)
Ask (Size)	10.50 (9)
Prev. Close	10.47
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate

November 17, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.

November 03, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Performance

More News

Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions

October 23, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions

October 17, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

October 04, 2023

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma

September 13, 2023

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma

July 10, 2023

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

June 12, 2023

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference

June 06, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments

April 27, 2023

From Healthwell Acquisition Corp. I

Via Business Wire

Healthwell Acquisition Corp. I Announces the Separate Trading of Its Class A Common Stock and Warrants Commencing September 23, 2021

September 22, 2021

From Healthwell Acquisition Corp. I

Via Business Wire

Frequently Asked Questions

Is Healthwell Acquisition Corp. I - Class A Common Stock publicly traded?

Yes, Healthwell Acquisition Corp. I - Class A Common Stock is publicly traded.

What exchange does Healthwell Acquisition Corp. I - Class A Common Stock trade on?

Healthwell Acquisition Corp. I - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Healthwell Acquisition Corp. I - Class A Common Stock?

The ticker symbol for Healthwell Acquisition Corp. I - Class A Common Stock is HWEL on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.